Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day

6.02	-0.02 / -0.33%
Data as of 4:00pm ET	Day’s Change

During After-Hours Switch to standard view »

6.02	0.00 / 0.00%
	Volume: 75,000

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +82.72% increase from the last price of 6.02.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19

Sales
$889.7K

Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.44%

Growthannually 38.21%

Sales

Growthquarterly 3.82%

Growthannually -1.88%

Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.